Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C
- 24 June 2009
- Vol. 27 (37) , 5142-5151
- https://doi.org/10.1016/j.vaccine.2009.06.027
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Differences in Hepatitis C Virus (HCV)-Specific CD8 T-Cell Phenotype during Pegylated Alpha Interferon and Ribavirin Treatment Are Related to Response to Antiviral Therapy in Patients Chronically Infected with HCVJournal of Virology, 2008
- Upregulation of PD-1 Expression on Circulating and Intrahepatic Hepatitis C Virus-Specific CD8+T Cells Associated with Reversible Immune DysfunctionJournal of Virology, 2007
- Analysis of CD127 and KLRG1 Expression on Hepatitis C Virus-Specific CD8 + T Cells Reveals the Existence of Different Memory T-Cell Subsets in the Peripheral Blood and LiverJournal of Virology, 2007
- Treating viral hepatitis C: efficacy, side effects, and complicationsGut, 2006
- Risk factors for hepatocellular carcinoma in HCV-cirrhosis: What we know and what is missingJournal of Hepatology, 2006
- Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: A randomized, placebo controlled trial for dose optimization in 128 healthy subjectsVaccine, 2006
- Immunization of Stage IV Melanoma Patients with Melan-A/MART-1 and gp100 Peptides plus IFN-α Results in the Activation of Specific CD8+ T Cells and Monocyte/Dendritic Cell PrecursorsCancer Research, 2006
- Natural history and predictors of disease severity in chronic hepatitis CJournal of Hepatology, 2006
- Mutational escape from CD8+ T cell immunityThe Journal of Experimental Medicine, 2005
- Immunology of hepatitis B virus and hepatitis C virus infectionNature Reviews Immunology, 2005